These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21161188)

  • 1. The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice.
    Kos T; Nikiforuk A; Rafa D; Popik P
    Psychopharmacology (Berl); 2011 Apr; 214(4):911-21. PubMed ID: 21161188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in rats.
    Nikiforuk A; Popik P
    Psychopharmacology (Berl); 2012 Mar; 220(1):65-74. PubMed ID: 21918808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats.
    Nikiforuk A; Gołembiowska K; Popik P
    Eur Neuropsychopharmacol; 2010 Jan; 20(1):37-48. PubMed ID: 19729284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtype-selective nicotinic acetylcholine receptor agonists can improve cognitive flexibility in an attentional set shifting task.
    Wood C; Kohli S; Malcolm E; Allison C; Shoaib M
    Neuropharmacology; 2016 Jun; 105():106-113. PubMed ID: 26772970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats.
    Popik P; Holuj M; Nikiforuk A; Kos T; Trullas R; Skolnick P
    Psychopharmacology (Berl); 2015 Mar; 232(6):1025-38. PubMed ID: 25260339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of clozapine on ketamine-induced deficits in attentional set shift task in mice.
    Szlachta M; Pabian P; Kuśmider M; Solich J; Kolasa M; Żurawek D; Dziedzicka-Wasylewska M; Faron-Górecka A
    Psychopharmacology (Berl); 2017 Jul; 234(14):2103-2112. PubMed ID: 28405711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketamine prevents stress-induced cognitive inflexibility in rats.
    Nikiforuk A; Popik P
    Psychoneuroendocrinology; 2014 Feb; 40():119-22. PubMed ID: 24485483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine.
    De Vry J; Jentzsch KR
    Behav Pharmacol; 2003 May; 14(3):229-35. PubMed ID: 12799525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct cognitive and discriminative stimulus effects of ketamine enantiomers in rats.
    Popik P; Khoo SY; Kuziak A; Golebiowska J; Potasiewicz A; Hogendorf A; Popik O; Matloka M; Moszczynski R; Nikiforuk A; Witkin JM
    Pharmacol Biochem Behav; 2020 Oct; 197():173011. PubMed ID: 32758523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat--a back translational study.
    Goetghebeur P; Dias R
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):287-93. PubMed ID: 18392753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism at the NR2B subunit of NMDA receptors induces increased connectivity of the prefrontal and subcortical regions regulating reward behavior.
    Gass N; Becker R; Sack M; Schwarz AJ; Reinwald J; Cosa-Linan A; Zheng L; von Hohenberg CC; Inta D; Meyer-Lindenberg A; Weber-Fahr W; Gass P; Sartorius A
    Psychopharmacology (Berl); 2018 Apr; 235(4):1055-1068. PubMed ID: 29305627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats.
    McLean SL; Beck JP; Woolley ML; Neill JC
    Behav Brain Res; 2008 May; 189(1):152-8. PubMed ID: 18282619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat.
    Higgins GA; Ballard TM; Enderlin M; Haman M; Kemp JA
    Psychopharmacology (Berl); 2005 Apr; 179(1):85-98. PubMed ID: 15759152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition.
    Higgins GA; Ballard TM; Huwyler J; Kemp JA; Gill R
    Neuropharmacology; 2003 Mar; 44(3):324-41. PubMed ID: 12604092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory.
    Smith JW; Gastambide F; Gilmour G; Dix S; Foss J; Lloyd K; Malik N; Tricklebank M
    Psychopharmacology (Berl); 2011 Sep; 217(2):255-69. PubMed ID: 21484239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative Allosteric Modulators Selective for The NR2B Subtype of The NMDA Receptor Impair Cognition in Multiple Domains.
    Weed MR; Bookbinder M; Polino J; Keavy D; Cardinal RN; Simmermacher-Mayer J; Cometa FN; King D; Thangathirupathy S; Macor JE; Bristow LJ
    Neuropsychopharmacology; 2016 Jan; 41(2):568-77. PubMed ID: 26105137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporally distinct cognitive effects following acute administration of ketamine and phencyclidine in the rat.
    Gastambide F; Mitchell SN; Robbins TW; Tricklebank MD; Gilmour G
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1414-22. PubMed ID: 23561394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia.
    Nikiforuk A; Hołuj M; Kos T; Popik P
    Neuropharmacology; 2016 Jun; 105():351-360. PubMed ID: 26826431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 5-hydroxytryptamine (serotonin) receptor 6 agonist EMD 386088 ameliorates ketamine-induced deficits in attentional set shifting and novel object recognition, but not in the prepulse inhibition in rats.
    Nikiforuk A; Fijał K; Potasiewicz A; Popik P; Kos T
    J Psychopharmacol; 2013 May; 27(5):469-76. PubMed ID: 23479455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced attention and impulsive action following NMDA receptor GluN2B-selective antagonist pretreatment.
    Higgins GA; Silenieks LB; MacMillan C; Sevo J; Zeeb FD; Thevarkunnel S
    Behav Brain Res; 2016 Sep; 311():1-14. PubMed ID: 27180168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.